Literature DB >> 7419702

Immunoglobulin G and immunoglobulin M antibody responses of patients with malignancies to the O antigens of bacteria causing bacteremia.

P J Gannon, M J Surgalla, J E Fitzpatrick, E Neter.   

Abstract

Malignancy may be associated with impairment of the immune system. In children with acute leukemia, an impaired immunoglobulin M (IgM) antibody response to poliovirus was documented previously. It was of interest, therefore, to determine the immunoclass of antibodies produced against the O antigens of bacteria causing bacteremia in patients with leukemia and other malignancies. For control purposes, parallel studies were carried out in patients without maligancies but with infections caused by gram-negative bacteria. The patients with malignancies were adults, and those without malignancies were children. The serum specimens were selected from patients mounting an antibody response. IgG and IgM antibodies were identified by mercaptoethanol reduction and chromatography. Antibody titers against the O antigens of enteric bacteria were determined by the hemagglutination procedure. Antibodies of both IgM and IgG immunoclasses were produced by all but 1 of 16 patients with leukemia and by all but 1 of 12 subjects with other malignancies. Thus, a specific IgM immune deficiency in adult patients with leukemia or other malignancies complicated by bacteremia was not present; however, the magnitude of the antibody response of the patient with leukemia was less than that of the subjets with other maligancies, with the median antibody titers of the former being 320 and those of the latter being 2,560.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7419702      PMCID: PMC273521          DOI: 10.1128/jcm.12.1.60-62.1980

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

Review 1.  Acute infections in cancer patients.

Authors:  S J Ketchel; V Rodriguez
Journal:  Semin Oncol       Date:  1978-06       Impact factor: 4.929

2.  Proceedings: Causes of death in cancer patients.

Authors:  J Inagaki; V Rodriguez; G P Bodey
Journal:  Cancer       Date:  1974-02       Impact factor: 6.860

3.  Poliovirus antibody response in patients with acute leukemia.

Authors:  P L Ogra; L F Sinks; D T Karzon
Journal:  J Pediatr       Date:  1971-09       Impact factor: 4.406

4.  Host-parasite interaction in patients with infections due to Escherichia coli. 3. Physicochemical characterization of O-specific antibodies in serum and urine.

Authors:  K L Vosti; J S Remington
Journal:  J Lab Clin Med       Date:  1968-07

5.  Antibody response of patients with malignancies to bacteremia with gram-negative bacteria.

Authors:  M J Surgalla; E Neter; J E Fitzpatrick
Journal:  J Clin Microbiol       Date:  1975-03       Impact factor: 5.948

6.  Pseudomonas aeruginosa infection and humoral antibody response of patients with cystic fibrosis.

Authors:  E Neter
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

7.  Antibody response to poliovirus immunization in childhood leukemia.

Authors:  S K Bosu; H Ciudad; L F Sinks; P I Ogra
Journal:  Med Pediatr Oncol       Date:  1975

8.  Duration of antibody responses to common enterobacterial and O antigens of children with pyogenic peritonitis.

Authors:  E K Griffiths; T C Jewett
Journal:  Infection       Date:  1976       Impact factor: 3.553

9.  Anti-Pseudomonas heat-stable opsonins in acute lymphoblastic leukemia of childhood.

Authors:  M R Wollman; L S Young; D Armstrong; M Haghbin
Journal:  J Pediatr       Date:  1975-03       Impact factor: 4.406

10.  Causes of death in adults with acute leukemia.

Authors:  H Y Chang; V Rodriguez; G Narboni; G P Bodey; M A Luna; E J Freireich
Journal:  Medicine (Baltimore)       Date:  1976-05       Impact factor: 1.889

View more
  1 in total

1.  Antibody response to the lipopolysaccharide and protein antigens of Salmonella typhi during typhoid infection. I. Measurement of serum antibodies by radioimmunoassay.

Authors:  R S Tsang; P Y Chau; S K Lam; J T La Brooy; D Rowley
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.